TW200510362A - Amorphous simvastatin calcium and methods for the preparation thereof - Google Patents
Amorphous simvastatin calcium and methods for the preparation thereofInfo
- Publication number
- TW200510362A TW200510362A TW093109089A TW93109089A TW200510362A TW 200510362 A TW200510362 A TW 200510362A TW 093109089 A TW093109089 A TW 093109089A TW 93109089 A TW93109089 A TW 93109089A TW 200510362 A TW200510362 A TW 200510362A
- Authority
- TW
- Taiwan
- Prior art keywords
- methods
- preparation
- simvastatin calcium
- amorphous
- amorphous simvastatin
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 3
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 title abstract 3
- 229910052791 calcium Inorganic materials 0.000 title abstract 3
- 239000011575 calcium Substances 0.000 title abstract 3
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 title abstract 3
- 229960002855 simvastatin Drugs 0.000 title abstract 3
- 239000002253 acid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45935203P | 2003-04-01 | 2003-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200510362A true TW200510362A (en) | 2005-03-16 |
Family
ID=33159646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093109089A TW200510362A (en) | 2003-04-01 | 2004-04-01 | Amorphous simvastatin calcium and methods for the preparation thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050004215A1 (zh) |
| EP (1) | EP1585717A1 (zh) |
| JP (1) | JP2006522142A (zh) |
| KR (1) | KR20050111629A (zh) |
| CN (1) | CN1795165A (zh) |
| CA (1) | CA2521095A1 (zh) |
| DE (1) | DE04758696T1 (zh) |
| ES (1) | ES2242556T1 (zh) |
| TW (1) | TW200510362A (zh) |
| WO (1) | WO2004089868A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2338904T3 (es) * | 2004-10-26 | 2010-05-13 | EISAI R&D MANAGEMENT CO., LTD. | Forma amorfa de compuestos de cinamida. |
| EP1954653A4 (en) * | 2005-11-23 | 2010-11-03 | Merck Sharp & Dohme | METHOD FOR PRODUCING AN AMORPHANT SOLID FOR WATER-INSOLUBLE PHARMACEUTICALS |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| US20080207900A1 (en) | 2007-02-28 | 2008-08-28 | Teiji Kimura | Two cyclic oxomorphorin derivatives |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| EP2559693B1 (en) | 2007-08-31 | 2014-11-26 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
| JP2021522332A (ja) * | 2018-04-25 | 2021-08-30 | 乳源▲東▼▲陽▼光▲薬▼▲業▼有限公司 | テネリグリプチン臭化水素酸塩アモルファス及びその調製方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444784A (en) * | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4582915A (en) * | 1983-10-11 | 1986-04-15 | Merck & Co., Inc. | Process for C-methylation of 2-methylbutyrates |
| US5159104A (en) * | 1991-05-01 | 1992-10-27 | Merck & Co., Inc. | Process to simvastatin ester |
| AU2001288724A1 (en) * | 2000-09-06 | 2002-03-22 | Merck & Co., Inc. | Dihydroxy open-acid salt of simvastatin |
| KR100407758B1 (ko) * | 2001-08-27 | 2003-12-01 | 씨제이 주식회사 | 스타틴의 제조에 있어서 락톤화 방법 |
-
2004
- 2004-04-01 EP EP04758696A patent/EP1585717A1/en not_active Withdrawn
- 2004-04-01 JP JP2006509559A patent/JP2006522142A/ja not_active Withdrawn
- 2004-04-01 WO PCT/US2004/009976 patent/WO2004089868A1/en not_active Application Discontinuation
- 2004-04-01 DE DE04758696T patent/DE04758696T1/de active Pending
- 2004-04-01 TW TW093109089A patent/TW200510362A/zh unknown
- 2004-04-01 CA CA002521095A patent/CA2521095A1/en not_active Abandoned
- 2004-04-01 KR KR1020057018805A patent/KR20050111629A/ko not_active Application Discontinuation
- 2004-04-01 US US10/815,362 patent/US20050004215A1/en not_active Abandoned
- 2004-04-01 ES ES04758696T patent/ES2242556T1/es active Pending
- 2004-04-01 CN CNA2004800145467A patent/CN1795165A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE04758696T1 (de) | 2005-12-29 |
| CA2521095A1 (en) | 2004-10-21 |
| KR20050111629A (ko) | 2005-11-25 |
| JP2006522142A (ja) | 2006-09-28 |
| ES2242556T1 (es) | 2005-11-16 |
| CN1795165A (zh) | 2006-06-28 |
| WO2004089868A1 (en) | 2004-10-21 |
| EP1585717A1 (en) | 2005-10-19 |
| US20050004215A1 (en) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216602A1 (zh) | 骨胳治療系統及方法 | |
| AU2003235891A1 (en) | Apparatus for producing sterilized water | |
| AU2003208804A1 (en) | Device for receiving animal food | |
| AU2003901867A0 (en) | Osseointegration fixation system for an implant | |
| AU2003901696A0 (en) | Implant magnet system | |
| HK1052450A1 (en) | Bone plate for osteosynthesis. | |
| AU2002229459A1 (en) | Bone plate | |
| AU2003203378A1 (en) | Suture insrument for biological use | |
| WO2006099219A3 (en) | Absorbable surgical fasteners | |
| AU2003210515A1 (en) | Methods for sterilizing tissue | |
| AU2003225946A1 (en) | Methods and compositions for vaccination against or involvingenterobacteriaceae bacteria | |
| GB0302026D0 (en) | Bioabsorbable implant | |
| AU2003208840A1 (en) | Sterilizing or disinfecting device | |
| MX2008001638A (es) | Metodo de espaciado de piel entumecida. | |
| AU2003240245A1 (en) | Osteosynthesis device | |
| DE60234250D1 (de) | Vorrichtung zur Zell- bzw. Gewebezüchtung | |
| TW200510362A (en) | Amorphous simvastatin calcium and methods for the preparation thereof | |
| AU2003211089A1 (en) | Vapor-dispensing device | |
| MX2008001269A (es) | Sistema de higiene. | |
| SG140447A1 (en) | Method of forming a micro-rotating device, and a micro-rotating device produced by the method | |
| AU2003271492A1 (en) | Bone fixation device | |
| AU2002951653A0 (en) | Fixation device | |
| AUPS113202A0 (en) | Remote examination supervision | |
| AU2003289546A1 (en) | Process for preparing simvastatin. | |
| AU2003220197A1 (en) | Adjustable suture anchor |